Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis
- PMID: 20132489
- PMCID: PMC2972722
- DOI: 10.1111/j.1365-2990.2010.01071.x
Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis
Abstract
Aim: To determine the spatial pattern of beta-amyloid (Abeta) deposition throughout the temporal lobe in Alzheimer's disease (AD).
Methods: Sections of the complete temporal lobe from six cases of sporadic AD were immunolabelled with antibody against Abeta. Fourier (spectral) analysis was used to identify sinusoidal patterns in the fluctuation of Abeta deposition in a direction parallel to the pia mater or alveus.
Results: Significant sinusoidal fluctuations in density were evident in 81/99 (82%) analyses. In 64% of analyses, two frequency components were present with density peaks of Abeta deposits repeating every 500-1000 microm and at distances greater than 1000 microm. In 25% of analyses, three or more frequency components were present. The estimated period or wavelength (number of sample units to complete one full cycle) of the first and second frequency components did not vary significantly between gyri of the temporal lobe, but there was evidence that the fluctuations of the classic deposits had longer periods than the diffuse and primitive deposits.
Conclusions: (i) Abeta deposits exhibit complex sinusoidal fluctuations in density in the temporal lobe in AD; (ii) fluctuations in Abeta deposition may reflect the formation of Abeta deposits in relation to the modular and vascular structure of the cortex; and (iii) Fourier analysis may be a useful statistical method for studying the patterns of Abeta deposition both in AD and in transgenic models of disease.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
Similar articles
-
A spatial pattern analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease.Folia Neuropathol. 2010;48(2):67-74. Folia Neuropathol. 2010. PMID: 20602287
-
Laminar distribution of beta-amyloid deposits in dementia with Lewy bodies and in Alzheimer's disease.Am J Alzheimers Dis Other Demen. 2006 Jun-Jul;21(3):175-81. doi: 10.1177/1533317506289256. Am J Alzheimers Dis Other Demen. 2006. PMID: 16869338 Free PMC article.
-
Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease.Dementia. 1995 May-Jun;6(3):121-5. doi: 10.1159/000106933. Dementia. 1995. PMID: 7620523
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?J Alzheimers Dis. 2010;22(2):345-55. doi: 10.3233/JAD-2010-100711. J Alzheimers Dis. 2010. PMID: 20847441 Review.
Cited by
-
Disturbance of phylogenetic layer-specific adaptation of human brain gene expression in Alzheimer's disease.Sci Rep. 2021 Oct 12;11(1):20200. doi: 10.1038/s41598-021-99760-5. Sci Rep. 2021. PMID: 34642398 Free PMC article.
-
Inhomogeneous distribution of Alzheimer pathology along the isocortical relief. Are cortical convolutions an Achilles heel of evolution?Brain Pathol. 2017 Sep;27(5):603-611. doi: 10.1111/bpa.12442. Epub 2016 Oct 18. Brain Pathol. 2017. PMID: 27564538 Free PMC article.
References
-
- Glenner GG, Wong CW. Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984;122:1131–1135. - PubMed
-
- Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ. Subtypes and differential laminar distribution of β/A4 deposits in Alzheimer’s disease: Relationship with the intellectual status of 26 cases. Acta Neuropathol. 1991;81:328–335. - PubMed
-
- Armstrong RA. β-amyloid plaques: stages in life history or independent origin? Dement Geriatr Cogn Disord. 1998;9:227–238. - PubMed
-
- Greenberg BD. The COOH-terminus of the Alzheimer amyloid Aβ peptide: Differences in length influence the process of amyloid deposition in Alzheimer brain, and tell us something about relationships among parenchymal and vessel-associated amyloid deposits. Amyloid. 1995;21:195–203.
-
- Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer’s disease. Arch Biochem Biophys. 1993;301:41–52. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 AG005681-259001/AG/NIA NIH HHS/United States
- U01-AG16976/AG/NIA NIH HHS/United States
- P30-AG13854/AG/NIA NIH HHS/United States
- P30-NS057105/NS/NINDS NIH HHS/United States
- P50-AG05681/AG/NIA NIH HHS/United States
- P01 AG003991-26S18678/AG/NIA NIH HHS/United States
- U01 AG016976-09S1/AG/NIA NIH HHS/United States
- P30 NS057105-04/NS/NINDS NIH HHS/United States
- P30 AG013854/AG/NIA NIH HHS/United States
- P01-AG03991/AG/NIA NIH HHS/United States
- P30 NS057105/NS/NINDS NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical